It was a pleasure to catch up with our Editorial Board member, Prof. Francesco Bandello (University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy), who talked us through his recent research on anti-vascular endothelial growth factor agents combined with laser for the treatment of proliferative diabetic retinopathy.
Questions
- Could you tell us a little about your recent research on the treatment of proliferative diabetic retinopathy with a combination of anti-VEGF agents and laser? (00:07)
- What has been the impact of the COVID-19 pandemic on Ophthalmology care and research? (03:40)
Speaker Disclosures: Prof. Francesco Bandello discloses the following relationships: Allergan, Bayer, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, SiFi, Thrombogenics, Zeiss
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of ESCRS 2020.
